{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T09:43:36Z","timestamp":1777715016018,"version":"3.51.4"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100024370","name":"Ministero dell'Istruzione dell'Universita e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["20202YAY9B"],"award-info":[{"award-number":["20202YAY9B"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["20203YAY9B"],"award-info":[{"award-number":["20203YAY9B"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["2022LHMF43"],"award-info":[{"award-number":["2022LHMF43"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ejphar.2025.177617","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T22:57:57Z","timestamp":1744412277000},"page":"177617","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["SGLT2 inhibitor dapagliflozin mitigates skeletal muscle pathology by modulating key proteins involved in glucose and ion homeostasis in an animal model of heart failure"],"prefix":"10.1016","volume":"997","author":[{"given":"Elena","family":"Conte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Imbrici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgia","family":"Dinoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1078-8490","authenticated-orcid":false,"given":"Brigida","family":"Boccanegra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7608-4026","authenticated-orcid":false,"given":"Martina","family":"Lanza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Mele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Antonietta","family":"Riemma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konrad","family":"Urbanek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donato","family":"Cappetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annamaria","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liberato","family":"Berrino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"De Angelis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Liantonio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejphar.2025.177617_bib1","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/jcsm.12968","article-title":"Targeting MuRF1 by small molecules in a HFpEF rat model improves myocardial diastolic function and skeletal muscle contractility","volume":"13","author":"Adams","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ejphar.2025.177617_bib2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.mito.2021.02.016","article-title":"Mitochondrion-driven nephroprotective mechanisms of novel glucose lowering medications","volume":"58","author":"Afsar","year":"2021","journal-title":"Mitochondrion"},{"issue":"4","key":"10.1016\/j.ejphar.2025.177617_bib3","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.yjmcc.2011.01.012","article-title":"CaMKII in myocardial hypertrophy and heart failure","volume":"51","author":"Anderson","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2025.177617_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.101966","article-title":"Neuromuscular junction transmission failure in aging and sarcopenia: the nexus of the neurological and muscular systems","volume":"89","author":"Arnold","year":"2023","journal-title":"Ageing Res. Rev."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177617_bib5","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/jcsm.12814","article-title":"Extracellular lipidome change by an SGLT2 inhibitor, luseogliflozin, contributes to prevent skeletal muscle atrophy in db\/db mice","volume":"13","author":"Bamba","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"12","key":"10.1016\/j.ejphar.2025.177617_bib6","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007198","article-title":"Skeletal muscle function, structure, and metabolism in patients with heart failure with reduced ejection fraction and heart failure with preserved ejection fraction","volume":"13","author":"Bekfani","year":"2020","journal-title":"Circ Heart Fail"},{"issue":"6","key":"10.1016\/j.ejphar.2025.177617_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129686","article-title":"Effects of nandrolone in the counteraction of skeletal muscle atrophy in a mouse model of muscle disuse: molecular biology and functional evaluation","volume":"10","author":"Camerino","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ejphar.2025.177617_bib9","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10735-010-9262-x","article-title":"Heart failure increases atrogin-1 and MuRF1 gene expression in skeletal muscle with fiber type-specific atrophy","volume":"41","author":"Carvalho","year":"2010","journal-title":"J. Mol. Histol."},{"issue":"4","key":"10.1016\/j.ejphar.2025.177617_bib10","doi-asserted-by":"crossref","first-page":"H1978","DOI":"10.1152\/ajpheart.01373.2005","article-title":"Differential modulation of Kv4.2 and Kv4.3 channels by calmodulin-dependent protein kinase II in rat cardiac myocytes","volume":"291","author":"Colinas","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"3","key":"10.1016\/j.ejphar.2025.177617_bib11","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/jcsm.12185","article-title":"Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia","volume":"8","author":"Conte","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ejphar.2025.177617_bib12","doi-asserted-by":"crossref","first-page":"714","DOI":"10.3389\/fphar.2020.00714","article-title":"Changes in expression and cellular localization of rat skeletal muscle ClC-1 chloride channel in relation to Age, myofiber phenotype and PKC modulation","volume":"11","author":"Conte","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177617_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1393746","article-title":"Branched-chain amino acids and L-alanine supplementation ameliorate calcium dyshomeostasis in sarcopenia: new insights for nutritional interventions","volume":"15","author":"Conte","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177617_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.635063","article-title":"Gain-of-Function STIM1 L96V mutation causes myogenesis alteration in muscle cells from a patient affected by tubular aggregate myopathy","volume":"9","author":"Conte","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejphar.2025.177617_bib15","doi-asserted-by":"crossref","unstructured":"Croteau, D., Luptak, I., Chambers, J.M., Hobai, I., Panagia, M., Pimentel, D.R., Siwik, D.A., Qin, F., Colucci, W.S. Effects of sodium-glucose linked transporter 2 inhibition with ertugliflozin on mitochondrial function, energetics, and metabolic gene expression in the presence and absence of diabetes mellitus in mice. J. Am. Heart Assoc. 10(13), e019995. doi: 10.1161\/JAHA.120.019995.","DOI":"10.1161\/JAHA.120.019995"},{"key":"10.1016\/j.ejphar.2025.177617_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceca.2021.102357","article-title":"Skeletal muscle mitochondria in health and disease","volume":"94","author":"De Mario","year":"2021","journal-title":"Cell Calcium"},{"issue":"10","key":"10.1016\/j.ejphar.2025.177617_bib17","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrcardio.2017.65","article-title":"Epidemiology of heart failure with preserved ejection fraction","volume":"14","author":"Dunlay","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"issue":"3","key":"10.1016\/j.ejphar.2025.177617_bib18","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1113\/JP280899","article-title":"Abnormal skeletal muscle blood flow, contractile mechanics and fibre morphology in a rat model of obese-HFpEF","volume":"599","author":"Espino-Gonzalez","year":"2021","journal-title":"J. Physiol."},{"issue":"5","key":"10.1016\/j.ejphar.2025.177617_bib19","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jshs.2023.04.001","article-title":"Skeletal muscle atrophy, regeneration, and dysfunction in heart failure: impact of exercise training","volume":"12","author":"Gallagher","year":"2023","journal-title":"J Sport Health Sci"},{"issue":"1","key":"10.1016\/j.ejphar.2025.177617_bib20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41572-024-00540-y","article-title":"Heart failure with preserved ejection fraction","volume":"10","author":"Hamo","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ejphar.2025.177617_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1057455","article-title":"Canagliflozin, characterized as a HDAC6 inhibitor, inhibits gastric cancer metastasis","volume":"12","author":"Jiang","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177617_bib22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.hfc.2007.12.002","article-title":"Exercise intolerance","volume":"4","author":"Kitzman","year":"2008","journal-title":"Heart Fail. Clin."},{"issue":"1 Pt 1","key":"10.1016\/j.ejphar.2025.177617_bib24","first-page":"E1","article-title":"Specific adaptations in muscle and adipose tissue in response to chronic systemic glucose oversupply in rats","volume":"273","author":"Laybutt","year":"1997","journal-title":"Am. J. Physiol."},{"issue":"18","key":"10.1016\/j.ejphar.2025.177617_bib25","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.3390\/ijms21186549","article-title":"Muscle wasting and sarcopenia in heart failure-the current state of science","volume":"21","author":"Lena","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177617_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116650","article-title":"Cardiovascular outcomes and molecular targets for the cardiac effects of sodium-glucose cotransporter 2 inhibitors: a systematic review","volume":"175","author":"Madonna","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"12","key":"10.1016\/j.ejphar.2025.177617_bib27","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s00424-017-2056-1","article-title":"Expression profiling and immunolocalization of Na+-D-glucose-cotransporter 1 in mice employing knockout mice as specificity control indicate novel locations and differences between mice and rats","volume":"469","author":"Maduni\u0107","year":"2017","journal-title":"Pfl\u00fcgers Archiv"},{"issue":"4","key":"10.1016\/j.ejphar.2025.177617_bib28","doi-asserted-by":"crossref","first-page":"H1597","DOI":"10.1152\/ajpheart.00484.2007","article-title":"Modulation of late sodium current by Ca2+, calmodulin, and CaMKII in normal and failing dog cardiomyocytes: similarities and differences","volume":"294","author":"Maltsev","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"7","key":"10.1016\/j.ejphar.2025.177617_bib29","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.3390\/biomedicines12071456","article-title":"Sympathetic activation promotes sodium glucose Co-Transporter-1 protein expression in rodent skeletal muscle","volume":"12","author":"Matthews","year":"2024","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.ejphar.2025.177617_bib31","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.bbabio.2012.11.014","article-title":"The function and the role of the mitochondrial glycerol-3-phosphate dehydrogenase in Mammalian tissues","volume":"1827","author":"Mr\u00e1\u010dek","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"8","key":"10.1016\/j.ejphar.2025.177617_bib32","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/CIRCRESAHA.108.175141","article-title":"Activation of Na+\/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure","volume":"103","author":"Nakamura","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2025.177617_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172810","article-title":"Empagliflozin restores lowered exercise endurance capacity via the activation of skeletal muscle fatty acid oxidation in a murine model of heart failure","volume":"866","author":"Nambu","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"18","key":"10.1016\/j.ejphar.2025.177617_bib34","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1161\/CIRCULATIONAHA.119.042929","article-title":"Dapagliflozin effects on biomarkers, symptoms, and functional status in patients with heart failure with reduced ejection fraction: the DEFINE-HF trial","volume":"140","author":"Nassif","year":"2019","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ejphar.2025.177617_bib35","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/iub.1323","article-title":"The Na(+)\/H(+) exchanger and pH regulation in the heart","volume":"66","author":"Odunewu-Aderibigbe","year":"2014","journal-title":"IUBMB Life"},{"issue":"3","key":"10.1016\/j.ejphar.2025.177617_bib36","doi-asserted-by":"crossref","first-page":"E322","DOI":"10.1152\/ajpendo.00091.2012","article-title":"The role of CaMKII in regulating GLUT4 expression in skeletal muscle","volume":"303","author":"Ojuka","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.ejphar.2025.177617_bib37","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1253\/circj.CJ-12-1235","article-title":"Exercise intolerance in chronic heart failure--skeletal muscle dysfunction and potential therapies","volume":"77","author":"Okita","year":"2013","journal-title":"Circ. J."},{"issue":"5","key":"10.1016\/j.ejphar.2025.177617_bib38","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00424-003-1110-3","article-title":"Diversity of the mammalian sodium\/proton exchanger SLC9 gene family","volume":"447","author":"Orlowski","year":"2004","journal-title":"Pfl\u00fcgers Archiv"},{"issue":"3","key":"10.1016\/j.ejphar.2025.177617_bib39","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1042\/BCJ20210700","article-title":"Differential effect of canagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, on slow and fast skeletal muscles from nondiabetic mice","volume":"479","author":"Otsuka","year":"2022","journal-title":"Biochem. J."},{"issue":"14","key":"10.1016\/j.ejphar.2025.177617_bib40","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/jama.2020.1906","article-title":"Effect of dapagliflozin on worsening heart failure and cardiovascular death in patients with heart failure with and without diabetes","volume":"323","author":"Petrie","year":"2020","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.ejphar.2025.177617_bib41","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11897-020-00468-w","article-title":"Heart failure-induced skeletal muscle wasting","volume":"17","author":"Philippou","year":"2020","journal-title":"Curr. Heart Fail. Rep."},{"issue":"6","key":"10.1016\/j.ejphar.2025.177617_bib43","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/jamacardio.2023.0957","article-title":"Skeletal muscle mitochondrial respiration and exercise intolerance in patients with heart failure with preserved ejection fraction","volume":"8","author":"Scandalis","year":"2023","journal-title":"JAMA Cardiol"},{"issue":"1","key":"10.1016\/j.ejphar.2025.177617_bib44","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12933-023-01754-2","article-title":"Targeting high glucose-induced epigenetic modifications at cardiac level: the role of SGLT2 and SGLT2 inhibitors","volume":"22","author":"Scisciola","year":"2023","journal-title":"Cardiovasc. Diabetol."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177617_bib45","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00392-022-02076-1","article-title":"Comorbidities complicating heart failure: changes over the last 15 years","volume":"112","author":"Screever","year":"2023","journal-title":"Clin. Res. Cardiol."},{"issue":"10","key":"10.1016\/j.ejphar.2025.177617_bib47","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1210\/jc.2019-00706","article-title":"The effects of dapagliflozin on systemic and renal vascular function display an epigenetic signature","volume":"104","author":"Solini","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1\u20132","key":"10.1016\/j.ejphar.2025.177617_bib48","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1023\/A:1027332523114","article-title":"Enhanced glycerol 3-phosphate dehydrogenase activity in adipose tissue of obese humans","volume":"54","author":"Swierczynski","year":"2003","journal-title":"Mol. Cell. Biochem."},{"issue":"9","key":"10.1016\/j.ejphar.2025.177617_bib49","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/cvr\/cvae095","article-title":"Empagliflozin inhibits increased Na influx in atrial cardiomyocytes of patients with HFpEF","volume":"120","author":"Trum","year":"2024","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2025.177617_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106659","article-title":"Dapagliflozin protects the kidney in a non-diabetic model of cardiorenal syndrome","volume":"188","author":"Urbanek","year":"2023","journal-title":"Pharmacol. Res."},{"issue":"25","key":"10.1016\/j.ejphar.2025.177617_bib51","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1016\/j.jacc.2023.04.034","article-title":"Effect of SGLT2 inhibitors on cardiovascular outcomes across various patient populations","volume":"81","author":"Usman","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.ejphar.2025.177617_bib52","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s00125-017-4509-7","article-title":"Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na+\/H+ exchanger, lowering of cytosolic Na+ and vasodilation","volume":"61","author":"Uthman","year":"2018","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.ejphar.2025.177617_bib53","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.yjmcc.2009.12.007","article-title":"Ca(2+)\/calmodulin-dependent protein kinase II contributes to intracellular pH recovery from acidosis via Na(+)\/H(+) exchanger activation","volume":"49","author":"Vila-Petroff","year":"2010","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"37","key":"10.1016\/j.ejphar.2025.177617_bib54","doi-asserted-by":"crossref","first-page":"25524","DOI":"10.1074\/jbc.M803043200","article-title":"Ca2+\/calmodulin-dependent protein kinase II-dependent remodeling of Ca2+ current in pressure overload heart failure","volume":"2283","author":"Wang","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.ejphar.2025.177617_bib55","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004129","article-title":"Fatigability, exercise intolerance, and abnormal skeletal muscle energetics in heart failure","volume":"10","author":"Weiss","year":"2017","journal-title":"Circ Heart Fail"},{"issue":"19","key":"10.1016\/j.ejphar.2025.177617_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231910989","article-title":"Empagliflozin preserves skeletal muscle function in a HFpEF Rat model","volume":"23","author":"Winzer","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.ejphar.2025.177617_bib57","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/ejhf.3192","article-title":"Sodium-glucose cotransporter 2 inhibitors influence skeletal muscle pathology in patients with heart failure and reduced ejection fraction","volume":"26","author":"Wood","year":"2024","journal-title":"Eur. J. Heart Fail."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177617_bib58","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ehf2.13121","article-title":"Skeletal muscle atrophy in heart failure with diabetes: from molecular mechanisms to clinical evidence","volume":"8","author":"Wood","year":"2021","journal-title":"ESC Heart Fail"},{"issue":"8","key":"10.1016\/j.ejphar.2025.177617_bib59","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1161\/01.RES.0000069686.31472.C5","article-title":"The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure","volume":"92","author":"Zhang","year":"2003","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.ejphar.2025.177617_bib60","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/FJC.0000000000001474","article-title":"Dapagliflozin attenuates heart failure with preserved ejection fraction remodeling and dysfunction by elevating \u03b2-Hydroxybutyrate-activated citrate synthase","volume":"82","author":"Zhang","year":"2023","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejphar.2025.177617_bib61","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s10741-012-9353-8","article-title":"Metabolic and structural impairment of skeletal muscle in heart failure","volume":"18","author":"Zizola","year":"2013","journal-title":"Heart Fail. Rev."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925003711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925003711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T12:17:14Z","timestamp":1745842634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925003711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":56,"alternative-id":["S0014299925003711"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177617","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SGLT2 inhibitor dapagliflozin mitigates skeletal muscle pathology by modulating key proteins involved in glucose and ion homeostasis in an animal model of heart failure","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177617","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"177617"}}